Available Measures
Analyst Forecasts -
 Last Month Revisions
Fiscal Period MeanHighLowMedian# of Estimates#Up#DownMean % Change
AnnualDec 194.996.774.134.901932-1.38
AnnualDec 184.705.394.094.6621314-1.52
AnnualDec 174.785.164.114.8922312-0.64
QuarterlyJun 171.131.281.001.1220811-0.29
QuarterlySep 171.251.370.921.2820415-2.41
QuarterlyDec 171.371.561.061.3820613-2.14
QuarterlyMar 181.141.211.071.12504-2.73
Long Term Growth 2.838.00-3.003.50302-29.58
Actuals -
  Reported EPSMean EstimateSurprise % Change
AnnualDec 165.145.110.57
QuarterlyJun 161.251.203.95
QuarterlySep 161.311.282.40
QuarterlyDec 161.381.352.52
QuarterlyMar 171.061.032.81
AnnualDec 155.425.44-0.38
AnnualDec 145.075.07-0.01
P/E Ratios
PeriodP/E Ratio
FY05.54
FY15.97
FY26.06
EPS Growth Rates
Growth RatesCompanyIndustryInd. Relative
FY1/FY0-7.082.300.908
FY2/FY1-1.52-0.310.988
FY3/FY26.125.191.009
Data Provided by Thomson Reuters

Disclaimer: Mean Earnings Estimates are calculated by First Call based on the earnings projections made by the analysts who cover Teva. Please note that any opinions, estimates or forecasts regarding TEVA's performance made by these analysts (and therefore the Mean Estimate numbers) are theirs alone and do not represent opinions, forecasts or predictions of Teva or its management. Teva does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.